Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma. (Q48646811)
Jump to navigation
Jump to search
scientific article published on 18 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma. |
scientific article published on 18 July 2014 |
Statements
1 reference
Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma. (English)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Rodolfo Montironi
1 reference
Ugo De Giorgi
1 reference
Roberto Iacovelli
1 reference
Cora N Sternberg
1 reference
Sergio Bracarda
1 reference
Mimma Rizzo
1 reference
Cinzia Ortega
1 reference
Francesco Massari
1 reference
Lisa Derosa
1 reference
Michele Milella
1 reference
Giuseppe Di Lorenzo
1 reference
Maria Pagano
1 reference
Rocco De Vivo
1 reference
Marta Rossi
1 reference
Chiara Paglino
1 reference
Linda Cerbone
1 reference
Giovanni Muzzonigro
1 reference
Luciano Burattini
1 reference
18 July 2014
1 reference
1 reference
193
1 reference
1
1 reference
41-47
1 reference
Identifiers
1 reference
1 reference